What’s your thoughts on the path forward. IMHO, because this is still passing the MDA with FDA and still will be used heavily by physicians for FX. Even those without 90% methylation. Plus...because there are 3 more indications ( particularly ASD, this is still a winner. Market over reaction has made this a very good buy ( if anyone has powder to spend now) . Curious about your thoughts.
News 
Market Data 
Discover 
